These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8678534)

  • 21. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study].
    Ohno H; Ishikawa T; Kitajima H; Nomura S; Suzuki T; Konishi H; Ohno Y; Onishi R; Konaka Y; Arima N; Doi S; Nasu K; Takahashi T; Tsudo M; Fukuhara S; Uchiyama T
    Rinsho Ketsueki; 2002 Mar; 43(3):170-5. PubMed ID: 11979748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated soluble CD4 levels in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Hanada S; Ishitsuka K; Ohno N; Otsuka M; Shimotakahara S; Nakahara K; Takeshita T; Chyuman Y; Kuwazuru Y
    Am J Hematol; 1994 Jun; 46(2):95-100. PubMed ID: 8172203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Syndrome of inappropriate antidiuretic hormone secretion associated with meningeal infiltration of tumor cells and elevated interleukin-1 beta and interleukin-6 in cerebrospinal fluid of a patient with adult T-cell leukemia].
    Imaizumi R; Fujiwara H; Matsumoto T; Matsumoto M; Matsushita K; Ohtsubo H; Hidaka S; Arima N; Tei C
    Rinsho Ketsueki; 2000 Feb; 41(2):140-5. PubMed ID: 10723244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
    Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Rzeski W
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):443-8. PubMed ID: 9437500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of lactate dehydrogenase isoenzyme in the cerebrospinal fluid of patients with acute lymphoblastic leukemia].
    Lesnichenko IF; Gubarenko NK; Gritsaev SV; Salmykova NB; Blinov MN
    Vopr Onkol; 2008; 54(1):59-61. PubMed ID: 18416059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
    Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
    Kamihira S; Atogami S; Sohda H; Momita S; Yamada Y; Tomonaga M
    Cancer; 1994 Jun; 73(11):2753-8. PubMed ID: 8194016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroleukemia in adults].
    Beslać-Bumbasirević Lj; Bosković D; Tomin D; Colović M; Kovacević M; Bumbasirević V
    Srp Arh Celok Lek; 1996; 124(3-4):82-6. PubMed ID: 9102825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
    Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Tura S; Papa G
    Cancer; 1994 Sep; 74(6):1792-800. PubMed ID: 8082082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
    Zerler B
    Cancer Cells; 1991 Dec; 3(12):471-9. PubMed ID: 1820093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.
    Chrobák L; Podzimek K; Plísková L; Kerekes Z; Zák P; Voglová J; Spacek J; Palicka V
    Neoplasma; 1996; 43(5):321-5. PubMed ID: 8996552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case series: CSF LDH, proteins and electrolyte levels in patients of acute lymphocytic leukemia.
    Rao D; Ghalaut VS; Ghalaut PS; Rao S
    Clin Chim Acta; 2012 Jul; 413(13-14):1045-8. PubMed ID: 22387722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia.
    Cacciola E; Calogero D; Marra G; Guglielmo P
    Boll Soc Ital Biol Sper; 1992 Apr; 68(4):259-62. PubMed ID: 1463600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma].
    Sciarra A; Stasi R; Stipa E; Masi M; Oliva F; Olivieri M; Perrotti A; Zaccari G; Amadori S; Papa G
    Recenti Prog Med; 1995 Feb; 86(2):57-62. PubMed ID: 7754173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
    Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
    Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The soluble IL-2 receptor in malignant hemopathies].
    Rupoli S; Montillo M; Salvi A; Brianzoni MF; Centurioni R; Cinciripini A; Paoletti P; Recchioni A; Leoni P
    Recenti Prog Med; 1992 Oct; 83(10):546-51. PubMed ID: 1462037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.